Found: 86
Select item for more details and to access through your institution.
Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 1, p. 47, doi. 10.1002/pds.1118
- By:
- Publication type:
- Article
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.
- Published in:
- Genome Biology, 2012, v. 13, n. 9, p. r79, doi. 10.1186/gb-2012-13-9-r79
- By:
- Publication type:
- Article
Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Factors Associated with Longitudinal Psychological and Physiological Stress in Health Care Workers During the COVID-19 Pandemic: Observational Study Using Apple Watch Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy.
- Published in:
- Patient, 2022, v. 15, n. 3, p. 353, doi. 10.1007/s40271-021-00561-9
- By:
- Publication type:
- Article
Are Adult Patients More Tolerant of Treatment Risks Than Parents of Juvenile Patients?
- Published in:
- Risk Analysis: An International Journal, 2009, v. 29, n. 1, p. 121, doi. 10.1111/j.1539-6924.2008.01135.x
- By:
- Publication type:
- Article
Review article: Putting some muscle into sarcopenia—the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 11, p. 1216, doi. 10.1111/apt.17498
- By:
- Publication type:
- Article
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 2, p. 205, doi. 10.1111/apt.17286
- By:
- Publication type:
- Article
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1534, doi. 10.1111/apt.16848
- By:
- Publication type:
- Article
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1442, doi. 10.1111/apt.16626
- By:
- Publication type:
- Article
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 281, doi. 10.1111/apt.16136
- By:
- Publication type:
- Article
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1658, doi. 10.1111/apt.16119
- By:
- Publication type:
- Article
Long‐term safety of vedolizumab for inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 8, p. 1353, doi. 10.1111/apt.16060
- By:
- Publication type:
- Article
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 669, doi. 10.1111/apt.15921
- By:
- Publication type:
- Article
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis—two cases in real world clinical practice. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1209, doi. 10.1111/apt.15735
- By:
- Publication type:
- Article
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 997, doi. 10.1111/apt.15716
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 271, doi. 10.1111/apt.15555
- By:
- Publication type:
- Article
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 10, p. 1068, doi. 10.1111/apt.15514
- By:
- Publication type:
- Article
Comment on 'Anti-Adhesion Therapies and the Rule of 3 for Rare Events'.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 7, p. 1083, doi. 10.1038/ajg.2014.117
- By:
- Publication type:
- Article
A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 7, p. 1051, doi. 10.1038/ajg.2012.89
- By:
- Publication type:
- Article
The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel Association.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 11, p. 2412, doi. 10.1038/ajg.2010.252
- By:
- Publication type:
- Article
Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 12, p. 3123, doi. 10.1111/j.1572-0241.2008.02176.x
- By:
- Publication type:
- Article
The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 11, p. 2925, doi. 10.1111/j.1572-0241.2008.02118.x
- By:
- Publication type:
- Article
Outcome of Surgical Versus Percutaneous Drainage of Abdominal and Pelvic Abscesses in Crohn's Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2006, v. 101, n. 10, p. 2283, doi. 10.1111/j.1572-0241.2006.00757.x
- By:
- Publication type:
- Article
Possible Association Between Isotretinoin and Inflammatory Bowel Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2006, v. 101, n. 7, p. 1569, doi. 10.1111/j.1572-0241.2006.00632.x
- By:
- Publication type:
- Article
Risk Factors for Colon Ischemia.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2004, v. 99, n. 7, p. 1333, doi. 10.1111/j.1572-0241.2004.21436.x
- By:
- Publication type:
- Article
Occurrence of Colon Ischemia in Relation to Irritable Bowel Syndrome.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2004, v. 99, n. 3, p. 486, doi. 10.1111/j.1572-0241.2004.04097.x
- By:
- Publication type:
- Article
Risk of early surgery for Crohn's disease: implications for early treatment strategies.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 12, p. 2712, doi. 10.1111/j.1572-0241.2003.08674.x
- By:
- Publication type:
- Article
Response to infliximab in fistulizing Crohn's disease is independent of baseline number of draining fistulas.
- Published in:
- 2003
- By:
- Publication type:
- Abstract
ASCA positivity is associated with increased risk for early surgery in Crohn's disease.
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 5, p. 1117, doi. 10.1111/j.1572-0241.2003.07418.x
- By:
- Publication type:
- Article
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Differences Between the 2016 and 2022 Food and Drug Administration Guidance—Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.
- Published in:
- Crohn's & Colitis 360, 2024, v. 6, n. 2, p. 1, doi. 10.1093/crocol/otae038
- By:
- Publication type:
- Article
Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1.
- Published in:
- Crohn's & Colitis 360, 2024, v. 6, n. 1, p. 1, doi. 10.1093/crocol/otad076
- By:
- Publication type:
- Article
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies.
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 4, p. 1, doi. 10.1093/crocol/otad070
- By:
- Publication type:
- Article
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00645-0
- By:
- Publication type:
- Article
Lessons Learned from the Ocean State Crohn's and Colitis Area Registry.
- Published in:
- Rhode Island Medical Journal, 2022, v. 105, n. 10, p. 38
- By:
- Publication type:
- Article
Effects of Growth Hormone Secretion on Body Composition in Patients with Crohn’s Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 11, p. 5468, doi. 10.1210/jc.2003-030608
- By:
- Publication type:
- Article
Efficient augmentation and relaxation learning for individualized treatment rules using observational data.
- Published in:
- Journal of Machine Learning Research, 2019, n. 30-56, p. 1
- By:
- Publication type:
- Article
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1270, doi. 10.1093/ecco-jcc/jjae038
- By:
- Publication type:
- Article
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 7, p. 1091, doi. 10.1093/ecco-jcc/jjae013
- By:
- Publication type:
- Article
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 12, p. 2012, doi. 10.1093/ecco-jcc/jjad112
- By:
- Publication type:
- Article
Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 10, p. 1689, doi. 10.1093/ecco-jcc/jjad067
- By:
- Publication type:
- Article
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 8, p. 1235, doi. 10.1093/ecco-jcc/jjad047
- By:
- Publication type:
- Article
Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 3, p. 338, doi. 10.1093/ecco-jcc/jjac141
- By:
- Publication type:
- Article
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1222, doi. 10.1093/ecco-jcc/jjac030
- By:
- Publication type:
- Article
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 6, p. 950, doi. 10.1093/ecco-jcc/jjab016
- By:
- Publication type:
- Article
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 1, p. 23, doi. 10.1093/ecco-jcc/jjz110
- By:
- Publication type:
- Article
The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1217, doi. 10.1093/ecco-jcc/jjz038
- By:
- Publication type:
- Article